Corresponding Author: Jane A. Cauley, DrPH,
University of Pittsburgh, 130 DeSoto St, Crabtree Hall A543, Pittsburgh, PA
15261 (jcauley@pitt.edu).
Author Contributions: Ms Lui had full access
to all of the data in the study and takes responsibility for the integrity
of the data and the accuracy of the data analysis.
Study concept and design: Cauley, Stone, Cummings.
Acquisition of data: Cauley, Ensrud, Stone,
Hochberg.
Analysis and interpretation of data: Cauley,
Lui, Ensrud, Zmuda, Stone, Hochberg.
Drafting of the manuscript: Cauley.
Critical revision of the manuscript for important
intellectual content: Lui, Ensrud, Zmuda, Stone, Hochberg, Cummings.
Statistical analysis: Lui, Stone.
Obtained funding: Cauley, Ensrud, Stone, Hochberg,
Cummings.
Administrative, technical, or material support:
Cauley, Zmuda.
Study supervision: Stone, Cummings.
Financial Disclosures: Dr Cauley has received
honoraria from Eli Lilly & Co, Merck & Co, and Novartis and has served
on the speaker’s bureau for Eli Lilly & Co and Merck & Co. No
other authors reported financial disclosures.
Funding/Support: Supported in part by Public
Health Service research grants AR35582, AR35583, AR35584, AR44811, and AG05407
from the National Institutes of Health.
Role of the Sponsors: The funding agencies
had no direct role in the conduct of the study, the collection, management,
statistical analyses, and interpretation of the data, preparation, or approval
of the manuscript.